Tianeptine

Zinosal 12,5 MG Comprimidos Recubiertos con Pelicula Efg

12,5 mg comprimido recubierto con películaSpainMarketedAuthorised 12 Aug 2014

In other countries

The same active substances on other registers, the same brand first.

Stablon 12.5MG Coated Tablet.Saudi Arabia · ServierSame form
STABLON TABLET 12.5 mgSingapore · 12.5 mg · tablet, sugar coated · Servier (S) Pte LTDSame form
StablonBrazil · Laboratórios Servier do Brasil LtdaSame substance
COAXIL 12,5 mgRomania · 12,5mg · draj. · Les Laboratoires ServierSame substance
LYXIT 12,5 mgRomania · 12,5 mg · compr. film. · Arena Group S.A.Same substance
NOBIXAL 12,5 mgRomania · 12,5mg · compr. film. · Antibiotice S.A.Same substance

Packs

Pack	Code	Status
ZINOSAL 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos (Blister PVC/PVDC-ALUMINIO)

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tianeptine

Zinosal 12,5 MG Comprimidos Recubiertos con Pelicula Efg

12,5 mg comprimido recubierto con películaSpainMarketedAuthorised 12 Aug 2014

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
ZINOSAL 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos (Blister PVC/PVDC-ALUMINIO)

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tianeptine
Strength: 12,5 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 12 Aug 2014
Registration: 78980
Marketing authorisation holder: Exeltis Healthcare S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica